3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Uterine Cervical Neoplasms
1
Prostatic Neoplasms
1
Pleural Effusion, Malignant
1
Paranasal Sinus Neoplasms
1
Papillomavirus Infections
1
Neoplasms
1
Nasopharyngeal Carcinoma
1
Melanoma
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
HIV Infections
1
Cervical Cancer Screening
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Interventions
Doxorubicin
20
Vincristine
17
Zidovudine
13
Cyclophosphamide
12
Bleomycin
12
Etoposide
10
Rituximab
6
Prednisone
6
Interferon alpha-2
6
Cytarabine
6
Liposomes
5
Filgrastim
5
Dexamethasone
5
tecogalan
4
sargramostim
4
Specimen Handling
4
Methotrexate
4
Magnetic Resonance Spectroscopy
4
Leucovorin
4
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
4
Fluorouracil
4
Biopsy
4
Peripheral Blood Stem Cell Transplantation
3
Paclitaxel
3
Nivolumab
3
interferon alfa-n1
2
fludarabine phosphate
2
fludarabine
2
cabozantinib
2
Whole-Body Irradiation
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
HIV Infections
×
Coal Tar
×
Clear all
NCT07225530
2026-02-25
(iSTAR)
Columbia University
Phase NA
Recruiting
600 enrolled